Anzeige
Mehr »
Sonntag, 05.07.2026 - Börsentäglich über 12.000 News
Milliardenkonkurrenten im Visier: Dieser KI-Wert gewinnt namhafte Großkunden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12CU5 | ISIN: KYG5438W1116 | Ticker-Symbol: L1PA
Frankfurt
03.07.26 | 15:25
0,109 Euro
+1,87 % +0,002
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
LEES PHARMACEUTICAL HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
LEES PHARMACEUTICAL HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,1100,12904.07.

Aktuelle News zur LEES PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
16.06.LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PROGRAM UNDER THE REPURCHASE MANDATE1
01.06.LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FUNDING APPROVED FOR SYNTHETIC SURFACTANT PROJECT1
27.05.Dividendenbekanntmachungen (27.05.2026)8.066 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AAC TECHNOLOGIES HOLDINGS INC ADR  US0003041052  0,0446 USD  0,0384 EUR  ADVANCE TERRAFUND REIT  BG1100025052 - 0,065 EUR  APOTEA AB  SE0023313762  0...
► Artikel lesen
21.05.LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 21 MAY 2026 - POLL RESULTS1
11.05.LEE'S PHARM (00950): CONNECTED TRANSACTION - INVESTMENT IN PARTNERSHIP FUND1
24.04.LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM-
24.04.LEE'S PHARM (00950): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM2
23.04.LEE'S PHARM (00950): PROXY FORM-
LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln
23.04.LEE'S PHARM (00950): NOTICE OF ANNUAL GENERAL MEETING-
23.04.LEE'S PHARM (00950): GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING-
23.04.LEE'S PHARM (00950): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 20251
23.04.LEE'S PHARM (00950): ANNUAL REPORT 2025-
30.03.LEE'S PHARM (00950): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20251
30.03.Lee's Pharmaceutical Holdings Ltd. Reports Retreat In Full Year Bottom Line1
30.03.LEE'S PHARM (00950): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025-
25.03.LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - APPROVAL OF INTRAROSA BY NMPA-
17.03.LEE'S PHARM (00950): NOTICE OF BOARD MEETING5
27.01.LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE-
11.12.25Lee's Pharmaceutical Holdings Limited: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights655Acquisition of Staccato One Breath Technology, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline...
► Artikel lesen
11.12.25Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights434Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee's Pharm's existing products...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1